Preferential cytoplasmic localization of p34(cdc2) in recurrent human squamous cell carcinoma after radiotherapy

Radiation Research

Volumn 147, Issue 3, 1997, Pages 277-283

  Cohen Jonathan, Elizabeth ^a,b   Toulas, Christine ^b   Rochaix, Philippe ^c   Bachaud, Jean Marc ^a   Daly Schveitzer, Nicolas ^a   Favre, Gilles ^b  

^a Department of Radiotherapy ^*  (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; PROTEIN KINASE;

ARTICLE; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME LOCALIZATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; PRIORITY JOURNAL; RADIOSENSITIVITY; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CDC2 PROTEIN KINASE; CYCLINS; CYTOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM RECURRENCE, LOCAL;

EID: 0031047295     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579333     Document Type: Article

References (30)

1. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
2. R. B. Bristow, A. Jang, J. Peacock, S. Chung, S. Benchimol and R. Hill, Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV 16-E7 and/or activated H-ras. Oncogene 9, 1527-1536 (1994).
3. S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh and M. B. Kastan, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495 (1992).
4. 1 arrest and apoptosis. Cancer Res. 54, 1169-1174 (1994).
5. 2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine. Radiat. Res. 140, 393-400 (1994).
6. L. J. Tolmach and P. M. Busse, The action of caffeine on X-irradiated HeLa cells. IV. Progression delays and enhanced cell killing at high caffeine concentrations. Radiat. Res. 82, 374-392 (1980).
7. F. Zampetti-Bossler and D. Scott, Cell death, chromosome damage and mitotic delay in normal human, ataxia-telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int. J. Radiat. Biol. 39, 547-558 (1981).
8. 2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat. Res. 125, 283-287 (1991).
9. L-N. Su and J. B. Little, Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen. Radiat. Res. 133, 73-79 (1993).
10. A. W. Murray, M. J. Solomon and M. W. Kirschner, The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature 339, 280-286 (1989).
11. M. Paggano, R. Pepperkok, F. Verde, W. Ansorge and G. Draetta, Cyclin A is required at two points in the human cell cycle. EMBO J. 11, 961-971 (1992).
12. cdc2 exclusively on Tyr 15. EMBO J. 12, 75-85 (1993).
13. J. P. Tassan, S. J. Schultz, J. Bartek and E. A. Nigg, Cell cycle analysis of the activity, subcellular location, and subunit composition of human CAK (CDK activating kinase). J. Cell. Biol. 127, 467-478 (1994).
14. J. Pines and T. Hunter, Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell. Biol. 115, 1-17 (1991).
15. J. Pines and T. Hunter, The differential location of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J. 13, 3772-3781 (1994).
16. R. J. Muschel, H. B. Zhang, G. Iliakis and W. G. McKenna, Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res. 51, 5113-5117 (1991).
17. A. Maity, W. G. McKenna and R. J. Muschel, Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J. 14, 603-609 (1995).
18. R. J. Muschel, H. B. Zhang and W. G. McKenna, Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in HeLa cells. Cancer Res. 53, 1128-1135 (1993).
19. cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to Etoposide. Cancer Res. 52, 1817-1822 (1992).
20. cdc2. Cancer Res. 54, 1412-1414 (1994).
21. M. F. Smeets, E. H. M. Mooren and A. C. Begg, The effect of radiation on G2 blocks, cyclin B expression and cdc2 expression in human squamous carcinoma cell lines with different radiosensitivities. Radiother. Oncol. 33, 217-227 (1994).
22. 2-phase arrest in HeLa cells. Radiat. Res. 143, 286-292 (1995).
23. S. Shi, M. E. Key and K. L. Kalra, Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 39, 741-748 (1991).
24. S. W. Sherwood, D. F. Rush, A. L. Kung and R. T. Schimke, Cyclin B1 expression in HeLa S3 cells studied by flow cytometry. Exp. Cell. Res. 211, 275-281 (1994).
25. S. Kakino, K. Sasaki, A. Kurose and H. Ito, Intracellular localization of cyclin B1 during the cell cycle in glioma cells. Cytometry 24, 49-54 (1996).
26. R. Datta, R. Hass, H. Gunji, R. Weichselbaum and D. Kufe, Down-regulation of cell cycle control genes by ionizing radiation. Cell Growth Differ. 3, 637-644 (1992).
27. 2 delay induced by nitro gen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J. Biol. Chem. 268, 8298-8308 (1993).
28. 2 arrest induced by nitrogen mustard. Proc. Nail. Acad. Sci. USA 91, 9480-9484 (1994).
29. cdc2/cyclin B. Cancer Res. 52, 1823-1829 (1992).
30. J. L. Schwartz, The role of constitutive and inducible processes in the response of human squamous cell carcinoma cell lines to ionizing radiation. Radiat. Res. 138, S37-S39 (1994).